Custom Research Report on Global Liquid Biopsy Market 2016 oct-26-2016 | Page 2

Global Liquid Biopsy Market According to the report "Liquid Biopsy Market", published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021. For full report refer to http://www.marketdataforecast.com/market-reports/globalliquid-biopsy-market-950/ Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-liquid-biopsy-market-950/request-sample Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period. Global market for Liquid Biopsy is segmented on the basis of By Cancer Type , Sample Type , By Diagnostic Approach and End Users 1. By Cancer Type: •Lung Cancer •Pancreatic Cancer •Leukemia •Other Visceral Cancers 2.By Sample Type: •Blood •Urine •Plasma •aliva •Cerebrospinal 3.By Diagnostic Approach: •Circulating Tumour cells (CTC) •Circulating Tumour DNA (ctDNA) •RNA in exosomes [phone] | www.marketdataforecast.com | [email protected]